In addition to the inverse relationship between TXNIP expression and STAT3 phosphorylation we find in BC cells, we further show that recombinant IL-24 treatment reduces STAT3 phosphorylation, supporting IL-24’s role in inhibiting STAT3 activation [62]. Here, IL24 is linked to breast cancer.